Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2011-08-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men
NCT07161973
The Anabolic Properties of Fortified Plant-based Protein in Older People
NCT05711095
The Impact of Milk Protein Glycation on Protein Digestion and Absorption
NCT05479916
Habitual Protein Intake and Muscle Protein Synthesis
NCT01986842
Muscle Perfusion and Protein Metabolism in Elderly
NCT00945256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nitrate
Sodium nitrate ingestion prior to ingesting intrinsically labeled protein
Nitrate
0.15 mmol/kg body weight sodium nitrate (dissolved in 250 mL water)
Sodium chloride
Sodium chloride placebo group
Sodium chloride
0.15 mmol sodium chloride dissolved in 250 mL water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nitrate
0.15 mmol/kg body weight sodium nitrate (dissolved in 250 mL water)
Sodium chloride
0.15 mmol sodium chloride dissolved in 250 mL water.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 70-85 years
* BMI \< 30 kg/m2
* Non insulin-dependent diabetes mellitus type 2 patients (T2DM) ( \>1 y since diagnoses)
Exclusion Criteria
* Hypertension (according to WHO criteria)\[29\] and/or cardiovascular disease treated with medication containing nitrates and/or having vasodilatory effects
* Use of medication, except for oral blood glucose lowering medication
* Use of insulin
* All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).
* HbA1c \> 10.0% (86 mmol/mol)
* Donated blood in last 3 months
* Diagnosed impaired renal or liver function
* Myocardial infarction within the last 3 years
* Gastric acid inhibitors
* Use of anti-coagulants
70 Years
85 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luc van Loon, PhD
Role: STUDY_DIRECTOR
Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gorissen SHM, Trommelen J, Kouw IWK, Holwerda AM, Pennings B, Groen BBL, Wall BT, Churchward-Venne TA, Horstman AMH, Koopman R, Burd NA, Fuchs CJ, Dirks ML, Res PT, Senden JMG, Steijns JMJM, de Groot LCPGM, Verdijk LB, van Loon LJC. Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans. J Nutr. 2020 Aug 1;150(8):2041-2050. doi: 10.1093/jn/nxaa024.
Kouw IW, Gorissen SH, Burd NA, Cermak NM, Gijsen AP, van Kranenburg J, van Loon LJ. Postprandial Protein Handling Is Not Impaired in Type 2 Diabetes Patients When Compared With Normoglycemic Controls. J Clin Endocrinol Metab. 2015 Aug;100(8):3103-11. doi: 10.1210/jc.2015-1234. Epub 2015 Jun 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-3-057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.